Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Antiva Biosciences Series D round, November 2, 2021
Antiva Biosciences raised a Series D round for 31,000,000 USD in November, 2021.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 21 Jan, 2023
Semyon Kolychev
edited on 21 Jan, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Date Announced
November 2, 2021
0
Funded Company
Antiva Biosciences
0
Funding Round Amount (USD)
31,000,000
0
Funding Type
Series D
0
Investment
Gaingels
0
Canaan Partners
0
Osage University Partners
0
Mana Ventures
0
Sofinnova Partners
0
Google Ventures
0
Adjuvant Capital
0
Lumira Ventures
0
Brace Pharma Capital
0
Sirona Capital
0
Alexandria Venture Investments
0
Dong-A ST
0
Avestria Ventures
0
Funding Round Date
November 2, 2021
0
Edits on 18 Jun, 2022
Semyon Kolychev
edited on 18 Jun, 2022
Edits made to:
Infobox
(
+14
properties)
Infobox
Announcement URL
https://www.prnewswire.com/news-releases/antiva-biosciences-closes-31-million-series-d-equity-financing-301413604.html
Investment
Gaingels
Canaan Partners
Osage University Partners
Mana Ventures
Sofinnova Partners
Google Ventures
Adjuvant Capital
Lumira Ventures
Brace Pharma Capital
Sirona Capital
Alexandria Venture Investments
Dong-A ST
Avestria Ventures
"Created via: Web app"
Semyon Kolychev
created this topic on 18 Jun, 2022
Edits made to:
Infobox
(
+5
properties)
Antiva Biosciences Series D round, November 2, 2021
Infobox
Is a
Funding round
Funding type
Series D
Funded company
Antiva Biosciences
Funding round amount (USD)
31,000,000
Date announced
November 2, 2021
Find more entities like Antiva Biosciences Series D round, November 2, 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE